Generate a tailored SOP for Dr. Godwin Aleku. Improve your application with a focused, well-structured draft.
Godwin Aleku is a Lecturer in the Drug Discovery Institute of Pharmaceutical Science at King's College London. He previously pursued his career as a clinical pharmacist focused on infectious diseases and held a senior regulatory affairs officer position at the National Agency for Food and Drug Administration and Control in Nigeria. He completed his MSc in Biotechnology Enterprise at the University of Exeter in 2013 and obtained his PhD in Chemical Biology from the University of Manchester in 2017, working under Professor Nicholas Turner FRS. His postdoctoral research took place at the Manchester Institute of Biotechnology until early 2020, where he collaborated with Professor David Leys. He has also spent time as an EMBO New Venture Fellow at ETH Zurich and served as a Leverhulme/Isaac Newton Trust Early Career Research Fellow at the University of Cambridge. Since joining King's College London in November 2022, Dr. Aleku leads interdisciplinary research aimed at developing clean enzyme-based sustainable pharmaceutical synthesis methods, focusing on biocatalysis in drug discovery. His research combines organic chemistry and industrial biotechnology with a strong emphasis on early-phase drug discovery.
Requirements are consistent across King's Business School and Social Science & Public Policy departments for standard Master's entries.